Peripheral Electrical Stimulation for the Treatment of Overactive Bladder

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05352945` - Effectiveness of HYPNOsis Masks During Botulinum TOXin Injections in Idiopathic Overactive Bladder(HypnoTox)	N/A
Recruiting	`NCT05387824` - Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder	N/A
Completed	`NCT04389307` - Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder	N/A
Recruiting	`NCT04444440` - Antibiotic Prophylaxis for Bladder Botox	Phase 4

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT05352945 - Effectiveness of HYPNOsis Masks During Botulinum TOXin Injections in Idiopathic Overactive Bladder(HypnoTox)

N/A

Recruiting

NCT05387824 - Tibial Nerve and Extracorporeal Magnetic Stimulation for Overactive Bladder

N/A

Completed

NCT04389307 - Intravaginal Electrical Stimulation in Idiopathic Overactive Bladder

N/A

Recruiting

NCT04444440 - Antibiotic Prophylaxis for Bladder Botox

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01783392
Study type	Interventional
Source	Sheffield Teaching Hospitals NHS Foundation Trust
Contact
Status	Completed
Phase	N/A
Start date	March 2013
Completion date	March 2015

Peripheral Electrical Stimulation for the Treatment of Overactive Bladder — PESTOB

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms